Pictet Asset Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CCM
VP
MFS
RGI
MA
Pictet Asset Management's MXCT Position: Q4 2024 in Review
Pictet Asset Management sold out of MaxCyte (MXCT) in Q4 2024, closing a stake of 14,535 shares — an estimated $56.5K sold.
Pictet Asset Management first reported a position in MXCT in Q3 2023 and held it in 5 quarters. The position peaked at $65.3K in Q4 2023. 119 funds tracked by Wall St. Rank hold MXCT as of Q4 2024.
- Pictet Asset Management reported no remaining MaxCyte position as of Q4 2024 after selling out during the quarter.
- Pictet Asset Management sold 14,535 MaxCyte shares in Q4 2024, an estimated $56.5K.
- Pictet Asset Management first reported a position in MaxCyte in Q3 2023 and held it in 5 quarters.
- Pictet Asset Management's MaxCyte position peaked at $65.3K in Q4 2023.
- 119 funds tracked by Wall St. Rank held MaxCyte as of Q4 2024.
Based on Pictet Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.